Skip to content

Left Atrial Geometry and Outcomes After Atrial Fibrillation Ablation

External Validation of the Left Atrial Sphericity as Predictor of Recurrence After Atrial Fibrillation Ablation: A Multicenter Observational Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02373982
Acronym
LAGO-FA
Enrollment
417
Registered
2015-02-27
Start date
2013-01-31
Completion date
2017-04-30
Last updated
2017-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Recurrence

Brief summary

This is a Multicenter Observational 1-year retrospective cohort study evaluating the predictive value of the Left Atrial Sphericity on the recurrence rate of atrial fibrillation after pulmonary vein ablation procedure. Inclusion of consecutive patients undergoing AF ablation during 2013 in whom a 3D-imaging of the left atrium (Cardiac CT or MRA) was acquired prior to the procedure and when procedural/follow-up data was prospectively collected.

Detailed description

Validation of the predictive value of the Left Atrial Sphericity for AF recurrence of atrial fibrillation after a pulmonary vein ablation procedure in an external, multicenter cohort. In total, 9 centers will include consecutive patients who underwent AF ablation from january to december 2013 in whom a 3D-imaging of the left atrium (Cardiac CT or MRA) was acquired prior to the procedure and when procedural/follow-up data was prospectively collected.

Interventions

None listed

Sponsors

Germans Trias i Pujol Hospital
CollaboratorOTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
CollaboratorOTHER
Hospital del Mar
CollaboratorOTHER
Hospital Virgen de la Salud
CollaboratorOTHER
Hospital San Carlos, Madrid
CollaboratorOTHER
Fundación para la Investigación del Hospital Clínico de Valencia
CollaboratorOTHER
Complejo Hospitalario Universitario de Vigo
CollaboratorOTHER
Puerta de Hierro University Hospital
CollaboratorOTHER
Hospital Clinic of Barcelona
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years old * First AF ablation procedure * Prior 3D-imaging of the left atrium (CT or MRA) * Prospective collection procedural and outcome data * Obtention of Informed Consent

Exclusion criteria

* Previous left atrial ablation or surgical procedure

Design outcomes

Primary

MeasureTime frame
Atrial Fibrillation Recurrence (>30 seconds)One Year

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026